skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

4757

International Journal of Chronic Obstructive Pulmonary Disease

(907,304) Views

Editor in Chief Dr Richard E Russell

1178-2005(R)

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
John A Marwick, Kian Fan Chung

A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD
Anita Nordenson, Anne Marie Grönberg, Lena Hulthén, et al.

Tiotropium bromide inhibits TGF-ß-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
Kazuhito Asano, Yusuke Shikama, Naruo Shoji, et al.

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy
Neeta Thakur, Paul D Blanc, Laura J Julian, et al

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters
L Pekka Malmberg, Paula Rytilä, Pertti Happonen, et al

Clinical efficacy of farcosolvin syrup (ambroxol–theophylline–guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis
Mostafa Yakoot, Amel Salem, Abdel-Mohsen Omar

Misdiagnosis of patients receiving inhaled therapies in primary care
José Luis Izquierdo, Antonio Martín, Pilar de Lucas, et al

Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
Imen Ben Cheikh Rejbi, Yassine Trabelsi, Afef Chouchene, et al

Lung function and blood markers of nutritional status in non-COPD aging men with smoking history: A cross-sectional study
Nobuyoshi Shiozawa, Kanae Hayashimoto, Etsuji Suzuki, et al

Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers
Florin Petrescu, Sebastian Cosmin Voican, Isabela Silosi

Nebulized formoterol: a review of clinical efficacy and safety in COPD
Nicholas J Gross, James F Donohue

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
Sonal Singh, Yoon K Loke NB
Editor-in-Chief comment: This paper further clarifies the role of steroids in COPD. It helps us to work out who should get ICS and who will benefit from ICS. We over prescribe ICS in COPD and this paper will hopefully make us think!


Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients
Anand A Dalal, Meaghan St Charles, Hans V Petersen, et al

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies
Eric Bateman, Dave Singh, David Smith, et al

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
Barbara P Yawn, Ibrahim Raphiou, Judith S Hurley, et al

Influencing the decline of lung function in COPD: use of pharmacotherapy
Ekaterina S Gladysheva, Atul Malhotra, Robert L Owens

A day at a time: caregiving on the edge in advanced COPD
A Catherine Simpson, Joanne Young, Margaret Donahue, et al NB
Editor-in-Chief comment: The burden of COPD is sometimes obvious; hospital admissions, morbidity and mortality. However there is enormous hidden costs to both patients and their relatives and carers. This paper explores these issues and furthers our understanding of COPD in all its aspects. As healthcare practitioners we need to learn to help not only our patients but also their carers.


Modified BODE indexes: Agreement between multidimensional prognostic systems based on oxygen uptake
José Luis Lopez-Campos, Pilar Cejudo, Eduardo Marquez, et al

Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation
Voicu Tudorache, Cristian Oancea, Ovidiu Fira Mlădinescu

Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population
Amir Sharafkhaneh, Nancy J Petersen, Hong-Jen Yu, et al

Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids
Violetta M Piotrowska, Wojciech J Piotrowski, Zofia Kurmanowska, et al

Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis
Donna Goodridge, Josh Lawson, Graeme Rocker, et al

Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD
Joseph Seaman, Anthony C Leonard, Ralph J Panos

Potential role of stem cells in management of COPD
Tillie L Hackett, Darryl A Knight, Don D Sin

Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines
Charlotte Suppli Ulrik, Ejvind Frausing Hansen, Michael Skov Jensen, et al

Impact of bronchodilator therapy on exercise tolerance in COPD
B Aguilaniu

Noninvasive ventilation: has Pandora’s box been opened?
Ari Manuel, Richard EK Russell, Quentin Jones

Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium
Donald P Tashkin

Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia
Simonetta Baldi, Roberto Aquilani, Gian Domenico Pinna, et al

Event-related evoked potentials in chronic respiratory encephalopathy
A R Al Tahan, R Zaidan, S Jones, et al

Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on healthrelated quality of life
Marc Miravitlles, Carles Llor, Jesús Molina, et al

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction
Barbara P Yawn, Douglas W Mapel, David M Mannino, et al

  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio

You may also be interested in the following related journals:

Journal of Asthma and Allergy
Lung Cancer: Targets and Therapy